Gynecomastia and hypertension.

L. Michael Prisant, Edward Chin

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Palpable dense and mobile subareolar tissue in the male breast defines the presence of gynecomastia. For the hypertension specialist, breast enlargement in men provides a clue to a secondary cause of hypertension or an adverse antihypertensive drug reaction. Hyperthyroidism, chronic renal failure, adrenal hyperplasia or tumors, amphetamine, cyclosporine, and anabolic steroids are secondary causes of hypertension associated with gynecomastia. Reserpine, methyldopa, and spironolactone are older drugs associated with gynecomastia; however, calcium antagonists (more commonly), angiotensin-converting enzyme inhibitors, and alpha1 blockers may also be associated with this finding. Treatment is directed to removal of the underlying cause.

Original languageEnglish (US)
Pages (from-to)245-248
Number of pages4
JournalJournal of clinical hypertension (Greenwich, Conn.)
Volume7
Issue number4
DOIs
StatePublished - Apr 2005

Fingerprint

Gynecomastia
Hypertension
Breast
Testosterone Congeners
Methyldopa
Spironolactone
Reserpine
Amphetamine
Hyperthyroidism
Drug-Related Side Effects and Adverse Reactions
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Cyclosporine
Chronic Kidney Failure
Hyperplasia
Calcium
Pharmaceutical Preparations
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Gynecomastia and hypertension. / Prisant, L. Michael; Chin, Edward.

In: Journal of clinical hypertension (Greenwich, Conn.), Vol. 7, No. 4, 04.2005, p. 245-248.

Research output: Contribution to journalReview article

Prisant, L. Michael ; Chin, Edward. / Gynecomastia and hypertension. In: Journal of clinical hypertension (Greenwich, Conn.). 2005 ; Vol. 7, No. 4. pp. 245-248.
@article{6fed9dbeb2d84524ba9683ec9b0bad58,
title = "Gynecomastia and hypertension.",
abstract = "Palpable dense and mobile subareolar tissue in the male breast defines the presence of gynecomastia. For the hypertension specialist, breast enlargement in men provides a clue to a secondary cause of hypertension or an adverse antihypertensive drug reaction. Hyperthyroidism, chronic renal failure, adrenal hyperplasia or tumors, amphetamine, cyclosporine, and anabolic steroids are secondary causes of hypertension associated with gynecomastia. Reserpine, methyldopa, and spironolactone are older drugs associated with gynecomastia; however, calcium antagonists (more commonly), angiotensin-converting enzyme inhibitors, and alpha1 blockers may also be associated with this finding. Treatment is directed to removal of the underlying cause.",
author = "Prisant, {L. Michael} and Edward Chin",
year = "2005",
month = "4",
doi = "10.1111/j.1524-6175.2005.04105.x",
language = "English (US)",
volume = "7",
pages = "245--248",
journal = "Journal of the CardioMetabolic Syndrome",
issn = "1524-6175",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Gynecomastia and hypertension.

AU - Prisant, L. Michael

AU - Chin, Edward

PY - 2005/4

Y1 - 2005/4

N2 - Palpable dense and mobile subareolar tissue in the male breast defines the presence of gynecomastia. For the hypertension specialist, breast enlargement in men provides a clue to a secondary cause of hypertension or an adverse antihypertensive drug reaction. Hyperthyroidism, chronic renal failure, adrenal hyperplasia or tumors, amphetamine, cyclosporine, and anabolic steroids are secondary causes of hypertension associated with gynecomastia. Reserpine, methyldopa, and spironolactone are older drugs associated with gynecomastia; however, calcium antagonists (more commonly), angiotensin-converting enzyme inhibitors, and alpha1 blockers may also be associated with this finding. Treatment is directed to removal of the underlying cause.

AB - Palpable dense and mobile subareolar tissue in the male breast defines the presence of gynecomastia. For the hypertension specialist, breast enlargement in men provides a clue to a secondary cause of hypertension or an adverse antihypertensive drug reaction. Hyperthyroidism, chronic renal failure, adrenal hyperplasia or tumors, amphetamine, cyclosporine, and anabolic steroids are secondary causes of hypertension associated with gynecomastia. Reserpine, methyldopa, and spironolactone are older drugs associated with gynecomastia; however, calcium antagonists (more commonly), angiotensin-converting enzyme inhibitors, and alpha1 blockers may also be associated with this finding. Treatment is directed to removal of the underlying cause.

UR - http://www.scopus.com/inward/record.url?scp=23844531297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844531297&partnerID=8YFLogxK

U2 - 10.1111/j.1524-6175.2005.04105.x

DO - 10.1111/j.1524-6175.2005.04105.x

M3 - Review article

C2 - 15860966

AN - SCOPUS:23844531297

VL - 7

SP - 245

EP - 248

JO - Journal of the CardioMetabolic Syndrome

JF - Journal of the CardioMetabolic Syndrome

SN - 1524-6175

IS - 4

ER -